Print me an organ -- Why are we not there yet?

December 11, 2019

3D bioprinting is a highly-advanced manufacturing platform that allows for the printing of tissue, and eventually vital organs, from cells. This could open a new world of possibilities for the medical field, while directly benefiting patients who need replacement organs.

Instead of waiting for a suitable donor or having the risk of their body rejecting a transplanted organ, 3D printed organs allow patients to have a customised organ fabricated specifically to replace their faulty ones. However, even with headway that 3D bioprinting has made in the last two decades, it is still lacking significant strides in order to produce complex 3D biomimetic tissue constructs.

According to researchers from the Singapore University of Technology and Design (SUTD), Nanyang Technological University (NTU) and Asia University, tissue culture techniques in particular require accelerated progress to address the bottleneck of maturing bioprinted multi-cellular 3D tissue constructs into functional tissues. Their research paper entitled "Print me an organ! Why are we not there yet?" has been published in the Progress in Polymer Science.

In the paper, researchers also provided in-depth review of recent improvements and analysed the bioprinting techniques, progress in bio-ink development, implementation of new bioprinting and tissue maturation strategies. Special attention was also given to the role of polymer science and how it complemented 3D bioprinting to overcome some of the major impediments such as achieving biomimicry, vascularization and 3D anatomically-relevant biological structures, in the field of organ printing (refer to image).

The use of complementary strategies such as dynamic co-culture perfusion system was seen as critical towards ensuring maturation and assembly of bioprinted tissue constructs. Even though it is now possible to fabricate human-scale tissues or organs that can potentially mature into vascularized and partially-functional tissues, the industry is still lagging behind in the bioprinting of human-specific tissues or organs due to the complexities in tissue-specific extracellular matrices (ECM) and tissue maturation process - the lack of suitable co-culture medium to support multiple types of cells and the need for further tissue conditioning prior to implantation.

"While 3D bioprinting is still in its early stages, the remarkable leap it has made in recent years points to the eventual reality of lab-grown, functional organs. However, to push the frontiers of medicine we must overcome the technical challenges in creating tissue-specific bio-inks and optimizing the tissue maturation process. This will ultimately have a huge impact on patients' lives, many of whom may be reliant on the future of 3D bioprinting," said Professor Chua Chee Kai, lead author of the paper from SUTD.

Singapore University of Technology and Design

Related Bioprinting Articles from Brightsurf:

Gel instrumental in 3D bioprinting biological tissues
The eventual creation of replacement biological parts requires fully three-dimensional capabilities that two-dimensional and three-dimensional thin-film bioprinting cannot supply.

Silk fibers improve bioink for 3D-printed artificial tissues and organs
Researchers from Osaka University processed silk fibers into a versatile component of bioink for 3D cell printing technology.

Preheating gelatin as a facile approach to increase 3D printing duration
SUTD researchers' new approach finds that preheating gelatin extended its 3D printing time compared to freshly prepared gelatin and enhanced the printability of the ink, which is essential for extrusion-based bioprinting and food printing.

Oxygen-releasing bioink for 3D bioprinting
Newly developed bioink enhances the ability of implanted cells to grow and regenerate new tissue

New microrobot with in situ, in vivo bioprinting offers promise for gastric wounds
Researchers in China have taken the first step towards a new way of treating gastric wounds by using a microrobot combined with the new concept of ''in situ in vivo bioprinting'' to carry out tissue repair inside the body.

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

New bioink for cell bioprinting in 3D
A research group led by Daniel Aili, associate professor at Linköping University, has developed a bioink to print tissue-mimicking material in 3D printers.

Synthesized cell culture process sets stage for more efficient cancer research
Researchers in Japan have replicated cancer cells from diseased bladder tissue in dogs, minimizing the use of costly stem cell products.

Research reveals insights into bioprinted skeletal muscle tissue models
SUTD collaborates with NTU to provide in-depth analysis of 3D in vitro biomimetic skeletal muscle tissue models, highlighting the great potential of bioprinting technology.

Cell-culture based test systems for anticancer drug screening
As we know, a malignant tumor is a complex system of mutated cells which constantly interacts with and involves healthy cells in the body.

Read More: Bioprinting News and Bioprinting Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to